COMMUNIQUÉS West-GlobeNewswire

CVRx to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call on August 6, 2026
23/07/2026
MINNEAPOLIS, July 23, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions [...]
Atos achieves CMMC 2.0 Level 2 certification, strengthening readiness for mission-critical and complex defense programs
23/07/2026
Irving, Texas, USA – July 23, 2026 – Atos IT Solutions and Services Inc. has achieved Cybersecurity Maturity Model Certification (CMMC) 2.0 Level 2 for its North America Managed Detection & Response (MDR) Security [...]
OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026
23/07/2026
MIAMI, July 23, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (OPKO) (NASDAQ: OPK), a fully-integrated healthcare company focused on delivering next-generation solutions for serious diseases across established global [...]
OKYO Pharma Announces Purchase of Shares by Director
23/07/2026
LONDON and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO ), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain ( [...]
Serotonin Centers Expands into Greater San Diego with New Del Mar Location
23/07/2026
Physician-Led Longevity Brand Brings Hormone Optimization, Medical Weight Loss, Peptide Therapy and Advanced Recovery Services to One of the Nation’s Most Health-Conscious Markets SAN DIEGO, July 23, 2026 (GLOBE [...]
Guerbet : H1 2026 revenue.
23/07/2026
H1 2026 revenue H1 activity Revenue of €379.2m at 30 June 2026, nearly stable at CER 1 and on a like-for-like basis 2 (-0.1%) A 2.5% decline in Q2 at CER and on a like-for-like basis, marked by a solid recovery in the [...]
Affidea accelerates its UK growth through strategic partnership with LIPS Healthcare
23/07/2026
LONDON, July 23, 2026 (GLOBE NEWSWIRE) -- Affidea, the pan-European provider of community-based clinics, advanced diagnostics, and specialist private healthcare services, today announces a strategic partnership with [...]
UPDATE - Omada Health to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 6, 2026
23/07/2026
SAN FRANCISCO, July 23, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its second quarter 2026 results on Thursday, August 6, [...]
Guerbet : Chiffre d’affaires du 1er semestre 2026.
23/07/2026
Chiffre d’affaires du 1 er semestre 2026 Activité semestrielle Chiffre d’affaires au 30 juin 2026 de 379,2 M€, quasiment stable à TCC 1 et périmètre comparable 2 (-0,1%) Au deuxième trimestre, un repli de 2,5% à TCC et [...]
First Choice Healthcare Solutions, Inc. Information on Share Consolidation
23/07/2026
MELBOURNE, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- First Choice Healthcare Solutions, Inc., (OTC: FCHS), (“ First Choice ” or the “ Company ”), announced today that as previously approved by the Board of Directors of [...]
Invitation to Idorsia's HY 2026 Financial Reporting webcast and conference call
23/07/2026
Idorsia will publish its Half Year 2026 Financial Reporting on Thursday July 30, at 07:00 CEST. An investor webcast and conference call will be held to discuss the results on the same day. Date: Thursday, July 30, 2026 [...]
Inhibikase Therapeutics Announces FDA Orphan Drug Designation Granted to IKT-001 for the Treatment of PAH
23/07/2026
WILMINGTON, Del., July 23, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing IKT-001 for Pulmonary Arterial Hypertension [...]
PetMeds Announces Proposed Sale-Leaseback of Headquarters and Distribution Center Buildings for $37 Million
23/07/2026
DELRAY BEACH, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx (Nasdaq: PETS), today announced that it has entered into a definitive agreement for a sale- [...]
Atsena Therapeutics Receives Orphan Designation from the European Medicines Agency (EMA) for ATSN-101 and ATSN-201
23/07/2026
Orphan designation provides market exclusivity and development benefits in the European Union as both programs advance in global pivotal clinical trials DURHAM, N.C., July 23, 2026 (GLOBE NEWSWIRE) -- Atsena [...]
Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities
23/07/2026
Strengthened capital position supports continued advancement of NB1 clinical development, manufacturing readiness and intellectual property initiatives through Q2 2027 BURLINGTON, Mass, July 23, 2026 (GLOBE NEWSWIRE [...]
Ardelyx to Report Second Quarter 2026 Financial Results on August 6, 2026
23/07/2026
Conference call scheduled for 4:30 p.m. Eastern Time WALTHAM, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX) (“Ardelyx” or the “Company”), a commercial-stage biopharmaceutical company focused on [...]
Outset Medical to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
23/07/2026
SAN JOSE, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, [...]
Collegium to Report Second Quarter 2026 Financial Results on August 6, 2026
23/07/2026
STOUGHTON, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading biopharmaceutical company focused on improving the lives of people living with serious and often misunderstood [...]
HCW Biologics Reaches Milestones for Its Proprietary Tetravalent Second-Generation T-Cell Engager Program On Track To Initiate Clinical Trials in First Half 2027
23/07/2026
Company requested Type B pre-IND meeting with U.S. FDA to discuss development and regulatory strategy for its investigational tetravalent T-cell engager, HCW11-018b HCW11-018b has demonstrated potential for treating [...]

Pages